Other than the financial motivations for enrolling in Phase I trials, research on how healthy volunteers perceive the benefits of their trial participation is scant. Using qualitative interviews conducted with 178 U.S. healthy volunteers enrolled in Phase I trials, we investigated how participants described the benefits of their study involvement, including, but not limited to, the financial compensation, and we analyzed how these perceptions varied based on participants’ sociodemographic characteristics and clinical trial history. We found that participants detailed economic, societal, and noneconomic personal benefits. We also found differences in participants’ perceived benefits based on gender, age, ethnicity, educational attainment, em...
As with all early-stage testing of investigational drugs, clinical trials targeting HIV/AIDS can pos...
A qualitative research study was conducted with people who had participated as healthy subjects in p...
The first stage of testing new pharmaceuticals in humans is referred to as a phase I clinical trial....
Background There is limited research on healthy volunteers’ perceptions of the risks of Phase I clin...
BackgroundThere is limited research on healthy volunteers’ perceptions of the risks of Phase I clini...
BackgroundThere is limited research on healthy volunteers' perceptions of the risks of Phase I clini...
Study goal: This study was carried out to answer the following research question: which motivation d...
Background/aims Financial compensation for research participation is a major focus of ethical concer...
Drawing on statistical data, this chapter illustrates the considerable variations in the backgrounds...
This is the dataset that was used for an article about the sociodemographic characteristics and part...
Objectives If patients are to reap the benefits of continued drug development, an understanding of w...
Background: Participation in clinical trials is critical for the success of evidence-based healthcar...
BACKGROUND: Participation in clinical trials is critical for the success of evidence-based healthcar...
BACKGROUND AND AIMS: This study was conducted to investigate the views of patients and healthy volun...
Phase I testing of investigational drugs relies on healthy volunteers as research participants. Many...
As with all early-stage testing of investigational drugs, clinical trials targeting HIV/AIDS can pos...
A qualitative research study was conducted with people who had participated as healthy subjects in p...
The first stage of testing new pharmaceuticals in humans is referred to as a phase I clinical trial....
Background There is limited research on healthy volunteers’ perceptions of the risks of Phase I clin...
BackgroundThere is limited research on healthy volunteers’ perceptions of the risks of Phase I clini...
BackgroundThere is limited research on healthy volunteers' perceptions of the risks of Phase I clini...
Study goal: This study was carried out to answer the following research question: which motivation d...
Background/aims Financial compensation for research participation is a major focus of ethical concer...
Drawing on statistical data, this chapter illustrates the considerable variations in the backgrounds...
This is the dataset that was used for an article about the sociodemographic characteristics and part...
Objectives If patients are to reap the benefits of continued drug development, an understanding of w...
Background: Participation in clinical trials is critical for the success of evidence-based healthcar...
BACKGROUND: Participation in clinical trials is critical for the success of evidence-based healthcar...
BACKGROUND AND AIMS: This study was conducted to investigate the views of patients and healthy volun...
Phase I testing of investigational drugs relies on healthy volunteers as research participants. Many...
As with all early-stage testing of investigational drugs, clinical trials targeting HIV/AIDS can pos...
A qualitative research study was conducted with people who had participated as healthy subjects in p...
The first stage of testing new pharmaceuticals in humans is referred to as a phase I clinical trial....